Creating a Telehealth Experience For Postoperative Appointments
Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
The Importance of Collaboration Between Mohs Surgeons and Urologists
Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
POLL: Would You Consider a Telehealth Option For Postoperative Appointments?
The question was a conversation starter after an ACMS clinical abstract presentation.
Making AI Work in Mohs Micrographic Surgery Workflow
An ACMS poster session delves into the role artificial intelligence can play in the treatment of basal cell carcinoma.
POLL: Do You Think AI Technology Can Enhance the Mohs Surgery Workflow?
A poster session and ACMS keynote speaker Anant Madabhushi, MS, PhD, both delve into the use of AI in Mohs surgery.
Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS
Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Looking Ahead to the 2023 ACMS Meeting
The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Plan Your Trip: Explore the Emerald City
If you are attending the 2023 ACMS Meeting, check out these local attractions to soak up the best of Seattle between sessions.
Rad Quotes From RAD 2023
Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
2023 Revolutionizing Atopic Dermatitis Recap
Catch up on all coverage from Revolutionizing Atopic Dermatitis.
Ruxolitinib Cream Provides Substantial, Sustained Itch Relief in AD Patients
A single-site study involving an adult cohort with atopic dermatitis saw significant itch improvement.
Discussing Disparities in AD With Andrew Alexis, MD, MPH
Alexis discusses his Revolutionizing Atopic Dermatitis session, “Disparities in the Care of Atopic Dermatitis in the United States.”
Assessing Itch Severity and Skin Clearance Supports Shared Decision Making
New data from RAD 2023 revealed the results of assessing the independent and combined effects of itch and skin severity on patient-reported symptoms and QoL.
Digital Educational Intervention Increases Awareness Among Hispanic Patients With AD
The study examined the impact of an educational intervention on the population with the highest prevalence of the disease.
Dupilumab Efficacious in Pediatric Patients as Young as 6 Months
The drug was both safe and effective in patients ages 6 months to 5 years.
Crucial Conversations Are Needed to Address Racism in Medicine
Candrice Heath, MD, FAAP, FAAD, reviewed the important conversations dermatologists need to have to understand how racism affects SOC patients with atopic dermatitis at RAD 2023.
POLL: Are You Attending the 2023 Annual Meeting of the American College of Mohs Surgery in Seattle?
Revolutionizing Atopic Dermatitis Recap: Day 3
Catch up on coverage from the third day of Revolutionizing Atopic Dermatitis.
Abrocitinib Has Acceptable Long-Term Safety Profile in Adolescents with AD
Researchers determined there were no unique safety concerns in the study, which spanned 1000 patient years.
Late-Breaking Data: Dupilumab Significantly Improves Signs, Symptoms, and QoL in Patients With Hand & Foot Dermatitis
Jonathan Silverberg, MD, PhD, MPH, presented late-breaking dupilumab data at RAD 2023.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS")
